341 related articles for article (PubMed ID: 29348737)
1.
Vuorimaa A; Rissanen E; Airas L
Contrast Media Mol Imaging; 2017; 2017():6975841. PubMed ID: 29348737
[TBL] [Abstract][Full Text] [Related]
2. Targeting adenosine A2A receptors in Parkinson's disease.
Schwarzschild MA; Agnati L; Fuxe K; Chen JF; Morelli M
Trends Neurosci; 2006 Nov; 29(11):647-54. PubMed ID: 17030429
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vivo Evaluation of Fluorine-18 and Iodine-123 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives as PET and SPECT Radiotracers for Mapping A2A Receptors.
Vala C; Morley TJ; Zhang X; Papin C; Tavares AA; Lee HS; Constantinescu C; Barret O; Carroll VM; Baldwin RM; Tamagnan GD; Alagille D
ChemMedChem; 2016 Sep; 11(17):1936-43. PubMed ID: 27407017
[TBL] [Abstract][Full Text] [Related]
4. Purinergic signaling in Parkinson's disease. Relevance for treatment.
Navarro G; Borroto-Escuela DO; Fuxe K; Franco R
Neuropharmacology; 2016 May; 104():161-8. PubMed ID: 26211977
[TBL] [Abstract][Full Text] [Related]
5. Potential Therapeutic Applications of Adenosine A
van Waarde A; Dierckx RAJO; Zhou X; Khanapur S; Tsukada H; Ishiwata K; Luurtsema G; de Vries EFJ; Elsinga PH
Med Res Rev; 2018 Jan; 38(1):5-56. PubMed ID: 28128443
[TBL] [Abstract][Full Text] [Related]
6. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of [
Zhou X; Khanapur S; de Jong JR; Willemsen AT; Dierckx RA; Elsinga PH; de Vries EF
J Cereb Blood Flow Metab; 2017 Feb; 37(2):577-589. PubMed ID: 26917190
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416.
Moresco RM; Todde S; Belloli S; Simonelli P; Panzacchi A; Rigamonti M; Galli-Kienle M; Fazio F
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):405-13. PubMed ID: 15549298
[TBL] [Abstract][Full Text] [Related]
9. Effects of the adenosine A
Prasad K; de Vries EFJ; van der Meiden E; Moraga-Amaro R; Vazquez-Matias DA; Barazzuol L; Dierckx RAJO; van Waarde A
Neuropharmacology; 2024 Apr; 247():109862. PubMed ID: 38325770
[TBL] [Abstract][Full Text] [Related]
10. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.
Tavares AA; Batis J; Barret O; Alagille D; Vala C; Kudej G; Koren A; Cosgrove KP; Nice K; Kordower JH; Seibyl J; Tamagnan GD
Nucl Med Biol; 2013 Apr; 40(3):403-9. PubMed ID: 23332393
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients.
Mishina M; Ishiwata K; Naganawa M; Kimura Y; Kitamura S; Suzuki M; Hashimoto M; Ishibashi K; Oda K; Sakata M; Hamamoto M; Kobayashi S; Katayama Y; Ishii K
PLoS One; 2011 Feb; 6(2):e17338. PubMed ID: 21386999
[TBL] [Abstract][Full Text] [Related]
14. Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A(2A) receptors with positron emission tomography.
Wang WF; Ishiwata K; Nonaka H; Ishii S; Kiyosawa M; Shimada J; Suzuki F; Senda M
Nucl Med Biol; 2000 Aug; 27(6):541-6. PubMed ID: 11056367
[TBL] [Abstract][Full Text] [Related]
15. First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX.
Ishiwata K; Mishina M; Kimura Y; Oda K; Sasaki T; Ishii K
Synapse; 2005 Feb; 55(2):133-6. PubMed ID: 15543628
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A(2A) receptor antagonists as Positron Emission Tomography (PET) tracers.
Khanapur S; Waarde Av; Ishiwata K; Leenders KL; Dierckx RA; Elsinga PH
Curr Med Chem; 2014; 21(3):312-28. PubMed ID: 24059232
[TBL] [Abstract][Full Text] [Related]
17. 11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.
Ishiwata K; Noguchi J; Wakabayashi S; Shimada J; Ogi N; Nariai T; Tanaka A; Endo K; Suzuki F; Senda M
J Nucl Med; 2000 Feb; 41(2):345-54. PubMed ID: 10688121
[TBL] [Abstract][Full Text] [Related]
18. Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
Barret O; Hannestad J; Alagille D; Vala C; Tavares A; Papin C; Morley T; Fowles K; Lee H; Seibyl J; Tytgat D; Laruelle M; Tamagnan G
J Nucl Med; 2014 Oct; 55(10):1712-8. PubMed ID: 25082853
[TBL] [Abstract][Full Text] [Related]
19. How do adenosine A
Mori A
Parkinsonism Relat Disord; 2020 Nov; 80 Suppl 1():S13-S20. PubMed ID: 33349575
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Structural Insight into Adenosine A
Karati D; Mukherjee S; Roy S
Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
